1. Academic Validation
  2. Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126

Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126

  • Peptides. 1990 Mar-Apr;11(2):193-7. doi: 10.1016/0196-9781(90)90070-l.
D L Vesely 1 L E Cornett S L MacLeod A A Nash J S Norris
Affiliations

Affiliation

  • 1 Department of Medicine, University of Arkansas for Medical Sciences, Little Rock.
Abstract

Two Peptides with vasodilatory properties consisting of Amino acids 1-30 and 31-67 of the 98 a.a. N-terminal end of the prohormone of atrial natriuretic factor (proANF) which circulates in man were investigated to determine if they have specific binding sites on membranes isolated from DDT1 MF-2 smooth muscle cells. Smooth muscle is a known biologic target of these Peptides. Competitive binding experiments revealed that proANFs (1-30), (31-67), and (99-126) (i.e., C-terminus; ANF) each had specific and separate binding sites. The dissociation constants for proANFs (1-30), (31-67), and (99-126) binding were 0.11 nM, 4 nM, and 7.3 nM, respectively. The binding site concentrations for proANFs (1-30), (31-67), and ANF were 2.57, 59.91 and 40 fmols/10(6) cells, respectively. The number of binding sites per cell were 1548, 36,087, and 24,090, respectively, for proANFs (1-30), (31-67), and (99-126) (ANF). Each peptide bound to DDT1 MF-2 membranes between 10(-8) to 10(-11) M but could only bind to the other peptides' receptors at concentrations of 10(-6) and 10(-7)M. These results suggest that proANF(1-30) and proANF(31-67) do not work through the ANF receptor but rather have their own separate and distinct receptors that mediate their biologic effects.

Figures